Soller, Lianne http://orcid.org/0000-0003-3542-3241
La Vieille, Sebastien
Cameron, Scott B.
Mak, Raymond
Cook, Victoria E.
Gerdts, Jennifer
Chan, Edmond S.
Funding for this research was provided by:
Health Canada
BC Children’s Hospital Foundation
Article History
Received: 30 March 2021
Accepted: 28 June 2021
First Online: 13 July 2021
Declarations
:
: This was a quality improvement study, and hence did not require review by an ethics committee.
: Not applicable.
: SBC has been a member of advisory boards for Bausch Health, and Pfizer, and was a committee member of the CSACI oral immunotherapy guidelines. RM has been a member of advisory boards for ALK, Sanofi; received speaker fees from AstraZeneca, Pediapharm, and Novartis. ESC has received research support from DBV Technologies; has been a member of advisory boards for Pfizer, Pediapharm, Leo Pharma, Kaleo, DBV, AllerGenis, Sanofi Genzyme, Bausch Health, Avir Pharma; is a member of the healthcare advisory board for Food Allergy Canada; was an expert panel and coordinating committee member of the National Institute of Allergy and Infectious Diseases (NIAID)-sponsored Guidelines for Peanut Allergy Prevention; and was co-lead of the CSACI oral immunotherapy guidelines. Other authors declare that they have no competing interests.